Calosyn Pharma
Shreveport, US
Biotech
Founders & leadership
JL
Joseph LovettDirector
RB
Richard BabbTreasurer
DW
David WaddellDirector
RP
Ross P. BarrettSecretary
WR
William R. GrimesPresident and Chief Executive Officer
Reported raises · per SEC filings
Form D private placements▶$750KraisedMar 2024 · 7 investors · BiotechnologyRule 506(b)
▶$750KraisedMar 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LovettDirector
- Richard BabbExecutive Officer, Director
- David WaddellDirector
- Ross P. BarrettExecutive Officer, Director
- William R. GrimesExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $750K
- Proceeds to insiders
- $144K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.